Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
KKR Entities, including Comet Asia Holdings and KKR Asia III Fund, have become significant shareholders in Australian Clinical Labs Ltd, acquiring a 5.12% voting power through over 10 million fully paid ordinary shares. This development marks a notable investment move, potentially impacting the company’s future market dynamics.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.